• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection and Management in Pharmacovigilance
  • News
  • Opinion
  • About
  • Glossary

Adverse Drug Reaction (ADR)

February 9, 2018 by Jose Rossello

An Adverse Drug Reaction (ADR) is a harmful or unpleasant reaction that occurs after the administration of a medication or a combination of medications. ADRs can vary in severity from mild, transient symptoms to severe, life-threatening reactions. They are distinct from medication side effects, which are known and expected reactions to a drug.

ADRs can be classified into several types:

  1. Type A (Augmented): These are dose-dependent and predictable reactions based on the drug’s pharmacological properties. Examples include bleeding from anticoagulants or hypoglycemia from insulin.
  2. Type B (Bizarre): These reactions are dose-independent, unpredictable, and not related to the pharmacological action of the drug. They include allergic reactions and idiosyncratic reactions.
  3. Type C (Chronic): Reactions that occur as a result of long-term drug therapy, such as corticosteroid-induced osteoporosis.
  4. Type D (Delayed): These reactions occur as a delayed response to a drug, such as carcinogenic effects from long-term use of certain medications.
  5. Type E (End of use): Reactions occurring when stopping a drug, such as withdrawal symptoms.
  6. Type F (Failure): This refers to drug failure, where the medication does not work as intended.

ADRs can happen to anyone but are more common in certain groups, such as the elderly, children, and people taking multiple medications. They can have a significant impact on a patient’s health and quality of life, and therefore, it’s important for healthcare providers to monitor for potential ADRs and manage them appropriately when they occur.

Related Articles:
  • Case Studies: Machine Learning Success in Pharmacovigilance – Analyzing Breakthroughs in Drug Safety Monitoring
  • How Generative AI is Transforming Pharmacovigilance: A Modern Approach
  • Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences
  • Sources of data
  • Glossary: Emerging Safety Issue
Related Terms:
  • Term: Adverse Drug Reaction (ADR)

Primary Sidebar

Subscribe in a reader

Search Website

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Signal Analytics Technology in Pharmacovigilance

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, … [Read More...] about Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

8 Common FDA Applications for Drugs & Biologics

The U.S. Food and Drug Administration (FDA) has several types of applications … [Read More...] about 8 Common FDA Applications for Drugs & Biologics

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Investigational New Drug (IND) applications represent a critical stage in the … [Read More...] about Key IND Enabling Studies: Navigating Preclinical Development Regulations

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field … [Read More...] about Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Regulatory authorities in the pharmaceutical industry have established standards … [Read More...] about Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

In the realm of patient safety and pharmacovigilance, statistical signal … [Read More...] about Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Pharmacovigilance signal detection software plays a crucial role in … [Read More...] about Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured … [Read More...] about What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Drug safety and pharmacovigilance are crucial aspects of public … [Read More...] about Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

he Development Safety Update Report (DSUR) is a crucial document that serves as … [Read More...] about Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

  • What is a DSUR (Development Safety Update Report)? An Essential Guide for Clinical Research
  • What is a BLA (Biologics License Application)? Essential Guide for Professionals
  • What is a PADER? – Periodic Adverse Drug Experience Report Explained

RSS ICH News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS From Nature journal

  • A disproportionality analysis of adverse events associated with ertapenem using the FAERS database from 2004 to 2024
  • Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting system
  • Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development
  • New insight into teratogenic effects of (S)-thalidomide in zebrafish embryos growing inside the chorion and subjected to electric pulses
  • A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in